» Authors » Susumu Ookawara

Susumu Ookawara

Explore the profile of Susumu Ookawara including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 144
Citations 576
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ito K, Ookawara S, Sanayama H, Kakuda H, Kanai C, Iguchi K, et al.
Sci Rep . 2025 Jan; 15(1):544. PMID: 39748056
Patients undergoing dialysis are at risk of osteoporosis and sarcopenia because of mineral and bone disorders or malnutrition. Additionally, maintaining muscle mass is important to prevent osteoporosis. The psoas muscle...
2.
Sunagawa K, Hirai K, Sunagawa S, Kamiya N, Komesu I, Sunagawa Y, et al.
Diabetes Metab Syndr Obes . 2024 Oct; 17:3767-3781. PMID: 39430135
Purpose: The aim of this study was to investigate the additional effects of empagliflozin on liraglutide in patients with advanced-stage type 2 diabetic kidney disease. Patients And Methods: Forty-one patients...
3.
Hirai K, Kitano T, Nakayama K, Morita F, Satomura H, Tanaka T, et al.
J Clin Med . 2024 Jul; 13(14). PMID: 39064247
: This cohort study was conducted to devise an approximation formula for predicting the glomerular filtration rate (GFR) after 1 year using annual medical examination data from the general population....
4.
Mutsuyoshi Y, Ito K, Ookawara S, Ueda Y, Shindo M, Hirata M, et al.
J Vasc Access . 2024 Jun; :11297298241257431. PMID: 38825801
Background: Vascular access, including arteriovenous fistula (AVF), is essential in patients undergoing hemodialysis (HD). However, the presence of AVF is non-physiological in humans and could pose a burden to the...
5.
Hirai K, Shimotashiro M, Okumura T, Ookawara S, Morishita Y
Int J Nephrol Renovasc Dis . 2024 May; 17:135-149. PMID: 38774113
Background: We assessed the anti-SARS-CoV-2 spike antibody response to four doses of BNT162b2 mRNA COVID-19 vaccine in Japanese hemodialysis patients and determined factors associated with the anti-SARS-CoV-2 spike antibody titer...
6.
Ookawara S, Ito K, Sasabuchi Y, Ueda Y, Morino J, Kaneko S, et al.
Kidney Blood Press Res . 2024 May; 49(1):368-376. PMID: 38735278
Introduction: Clinical studies on differences among changes in cerebral and hepatic oxygenation during hemodialysis (HD) in patients with and without intradialytic hypotension (IDH) are limited. We investigated changes in intradialytic...
7.
Nagao N, Yabe H, Hirai K, Hiruta M, Ookawara S, Morishita Y, et al.
Int J Rheum Dis . 2024 May; 27(5):e15169. PMID: 38706213
No abstract available.
8.
Hirata M, Ito K, Ookawara S, Tanno K, Morino J, Minato S, et al.
Cureus . 2024 Apr; 16(3):e56347. PMID: 38633934
Introduction: Many patients with chronic kidney disease (CKD), including peritoneal dialysis (PD), have sarcopenia. It is important to evaluate muscle mass to prevent sarcopenia in the field of CKD management....
9.
Hirai K, Shimotashiro M, Okumura T, Ookawara S, Morishita Y
Kidney Res Clin Pract . 2024 Feb; 43(3):326-336. PMID: 38389151
Background: We assessed the anti-SARS-CoV-2 spike antibody response to the third dose of BNT162b2 mRNA COVID-19 vaccine in Japanese hemodialysis patients and determined factors associated with the anti-SARS-CoV-2 spike antibody...
10.
Watanabe Y, Hirai K, Hirata M, Kitano T, Ito K, Ookawara S, et al.
BMC Nephrol . 2024 Feb; 25(1):53. PMID: 38336671
Background: Minimal change nephrotic syndrome (MCNS) can be complicated by thymoma; however, no standard therapy for thymoma-associated MCNS has yet been established. We herein describe a case of steroid-resistant MCNS...